Diabetes Brand Sites Rank Highest

Article

Manhattan Research, a healthcare market research company, released a survey on Monday announcing the top 10 pharmaceutical product sites visited by physicians.

Manhattan Research, a healthcare market research company, released a survey on Monday announcing the top 10 pharmaceutical product sites visited by physicians. Four of the top sites were diabetes drug sites: Januvia, Actos, Byetta, and Avandia. The rise in attention to some of these sites has been somewhat attributed to the continuously changing treatment options. While, until recently, there were only sulfonylureas and insulin available for type 2 diabetes treatments, today the options for treatment have multiplied. Notable controversies regarding drugs such Avandia and Byetta have most likely added to physician traffic to those sites.

Meredith Abreu Ressi, VP of Research at Manhattan Research, commented in a press release that the "rankings show that market events, rather than just advertising alone, can be critical drivers to brand websites…Pharmaceutical companies need to ensure that brand websites contain the latest, most accurate content possible and can be found relatively easily by physicians using search engines to research pharmaceutical information."

Top 10 Pharma Product Websites among Physicians in 2008:

  1. Januvia
  2. Actos
  3. Chantix
  4. Gardasil
  5. Actonel
  6. Vytorin
  7. Amitiza
  8. Byetta
  9. Avandia
  10. Aciphex

Source: ePharma Physician(R) v8.0 (2008)

What pharmaceutical sites do you visit the most? Have these drug sites been useful to you? Are these sites your primary source for drug information for these drugs? Do you trust the content that you find on these sites? We’d love to hear from you!

Related Videos
Alexandra Louise Møller, MS, PhD | Credit: LinkedIn
A panel of 5 experts on Cushing's syndrome
A panel of 5 experts on Cushing's syndrome
Optimizing Diabetes Therapies with New Classifications
Vlado Perkovic, MBBS, PhD | Credit: George Institute of Global Health
Should We Reclassify Diabetes Subtypes?
What Should the American Academy of Physician Associates Focus on in 2025?
GLP-1 Agonist Safety Risks and Obesity Stigma with Kevin Peterson, MD, MPH
Video 8 - "Pathophysiology of Hypercortisolism"
Video 7 - "Evolving Perception of Autonomous Adrenal Hypercortisolism "
© 2024 MJH Life Sciences

All rights reserved.